These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 378575)

  • 1. Nonspecific resistance of Serratia marcescens against antimicrobial drugs. Resistance or decreased susceptibility of phenotypic variants against chloramphenicol, nalidixic acid, nitrofurantoin, sulfonamides and trimethoprim.
    Traub WH; Fukushima PI
    Chemotherapy; 1979; 25(4):196-203. PubMed ID: 378575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. I. Cotrimoxazole, nalidixic acid, nitrofurantoin, and trimethoprim.
    Traub WH
    Chemotherapy; 1982; 28(5):369-80. PubMed ID: 6754280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selected and spontaneous variants of Serratia marcescens with combined resistance against chloramphenicol, nalidixic acid, and trimethoprim.
    Traub WH; Kleber I
    Chemotherapy; 1977; 23(6):436-51. PubMed ID: 336309
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro additive effect of nitrofurantoin combined with trimethoprim-sulfamethoxazole against Serratia marcescens.
    Traub WH; Fukushima PI
    Chemotherapy; 1979; 25(3):140-6. PubMed ID: 378572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobials commonly used for urinary tract infection: sulfonamides, trimethoprim-sulfamethoxazole, nitrofurantoin, nalidixic acid.
    Keys TF
    Mayo Clin Proc; 1977 Nov; 52(11):680-2. PubMed ID: 926843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incomplete cross-resistance of nalidixic and pipemidic acid-resistant variants of Serratia marcescens against ciprofloxacin, enoxacin, and norfloxacin.
    Traub WH
    Chemotherapy; 1985; 31(1):34-9. PubMed ID: 3156026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro sensitivity of hospital strains of Serratia marcescens to chemotherapeutic agents.
    Verbist L; Spaepen J; Vandepitte J
    Chemotherapy; 1976; 22(1):43-54. PubMed ID: 767065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Sensitivity tests in various potentially pathogenic microorganisms].
    Jedicková Z; Aldová E
    Z Gesamte Inn Med; 1972 Jan; 27(1):41. PubMed ID: 4335602
    [No Abstract]   [Full Text] [Related]  

  • 9. Sensitivity studies on Serratia strains from clinical specimens.
    von Graevenitz A
    Chemotherapy; 1967; 12(4):215-25. PubMed ID: 4863818
    [No Abstract]   [Full Text] [Related]  

  • 10. The susceptibility of Serratia marcescens to sulfamethoxazole, trimethoprim, and trimethoprim-sulfamethoxazole.
    Adeniyi-Jones C; Neilly S; Roberts RS; Kaufmann NR
    J Infect Dis; 1973 Nov; 128():Suppl:534-42 p. PubMed ID: 4585956
    [No Abstract]   [Full Text] [Related]  

  • 11. Characterization of a nosocomially significant, multiple drug-resistant strain of Serratia marcescens.
    Traub WH; Kleber I; Pühler A; Burkardt HJ
    Chemotherapy; 1976; 22(5):297-312. PubMed ID: 181215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic sensitivity of Escherichia coli.
    Williams RF
    Br Med J; 1973 Feb; 1(5848):297. PubMed ID: 4568145
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug resistance, R plasmids and pigmentation of Serratia marcescens isolated in Taiwan.
    Ding MJ; Sung SJ
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):69-79. PubMed ID: 3297535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salicylate induction of phenotypic resistance to quinolones in Serratia marcescens.
    Berlanga M; Viñas M
    J Antimicrob Chemother; 2000 Aug; 46(2):279-82. PubMed ID: 10933653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sensitivity range of gram-negative microorganisms and mycoplasms to minocycline in vitro].
    Schmid E; Price P; Krech U
    Arzneimittelforschung; 1974 Sep; 24(9):1256-8. PubMed ID: 4373015
    [No Abstract]   [Full Text] [Related]  

  • 16. [Sensitivity of Serratia marcescens to chemotherapy].
    Neguţ M; Niţulescu A; Potcoavă R
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol; 1978; 23(1):27-36. PubMed ID: 349661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vivo and in vitro potentiation of sulfamethoxazole by trimethoprim against strains of Serratia marcescens.
    Grunberg E; Beskid G; DeLorenzo WF; Cleeland R
    Int J Clin Pharmacol; 1973 Aug; 8(1):47-50. PubMed ID: 4580383
    [No Abstract]   [Full Text] [Related]  

  • 18. Gram-negative urinary tract isolates in southwestern Ontario.
    Black WA; Hatch LA
    J Urol; 1973 Apr; 109(4):692-4. PubMed ID: 4571911
    [No Abstract]   [Full Text] [Related]  

  • 19. Susceptibility of different isolates of Vibrio harveyi to antibiotics.
    Liu PC; Lee KK; Chen SN
    Microbios; 1997; 91(368-369):175-80. PubMed ID: 9523424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rapid method for microbial resistance testing in urinary tract infections?].
    Hotz R; Binswanger U
    Schweiz Med Wochenschr; 1972 Nov; 102(45):1656-9. PubMed ID: 4486570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.